Dr. Moran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2973 Woodside Rd
Woodside, CA 94062Phone+1 650-851-0565Fax+1 650-851-0520
Education & Training
- University of TorontoFellowship, 1992 - 1993
- Boston University Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1988 - 1992
- Tufts Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1988 - 1992
- St Elizabeth's Medical CenterInternship, Surgery, 1987 - 1988
- University of Michigan Medical SchoolClass of 1987
- Universtiy of MichiganB.S., Biomedical Science, 1985
Certifications & Licensure
- CA State Medical License 1993 - 2025
- TN State Medical License 2016 - 2025
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Facial Plastic and Reconstructive SurgeryFacial Plastic Surgery
Awards, Honors, & Recognition
- President American Academy of Facial Plastic and Reconstructive Surgery, 2019-2020
- Larry Schoenrock Award American Board of Facial Plastic and Reconstructive Surgery, 2018
Clinical Trials
- Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines Start of enrollment: 2019 Jun 17
Publications & Presentations
PubMed
- 188 citationsA phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.John A. Wagner, Ilynn B. Nepomuceno, Anna H. Messner, Mary Lynn Moran, Eric P. Batson
Human Gene Therapy. 2002-07-20 - 162 citationsEfficient and persistent gene transfer of AAV-CFTR in maxillary sinusJohn A. Wagner, Thomas Reynolds, Mary Lynn Moran, Richard B. Moss, Jeffrey J. Wine
Lancet. 1998-06-06 - 147 citationsSafety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.John A. Wagner, Anna H. Messner, Mary Lynn Moran, Richard Daifuku, Keisuke Kouyama
The Laryngoscope. 1999-02-01
Journal Articles
- Office-based periorbital rejuvenationMoran ML, Facial Plast Surg, 2/2013
- Scar Revision: Management of Facial Cutaneous Defects, Part IIMoran ML, Otolaryngologic Clinics of North America, 8/1/2001
- Safety and Biological Efficacy of AAV-CFTR in the CF Maxillary SinusWagner JA, Messner AH, Moran ML et al, Laryngoscope, 2/1/1999
- Join now to see all
Books/Book Chapters
Lectures
- Management of Sinusitis in the Patient with Cystic FibrosisWashington, D.C. - 9/1/2000
- Topical Therapy for Chronic Sinusitis in Cystic Fibrosis PatientsUCSF and University of Cincinnati Medical Schools Departments of Otolaryngology/Head and Neck Surger - 6/23/1998
- The Devastated NoseStanford University Medical School, Department of Otolaryngology-Head and Neck Surgery - 5/21/1998
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: